HIGHLIGHTS
- who: Minna Mecklin from the (UNIVERSITY) have published the research: Multicenter cohort study on duration of antiarrhythmic medication for supraventricular tachycardia in infants, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate and compare the recurrence of SVT in infants treated for 6 months with AM in 2013-2017 and infants treated for 12 months with AM in 2005-2012.
SUMMARY
To prevent heart failure and mortality, infants with SVT are treated prophylactically with antiarrhythmic medication (AM) as long as the risk of recurrent SVT exists. Fortunately . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.